Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Hepatocellular Carcinoma”

467 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 467 results

Not applicableLooking for participantsNCT05444478
What this trial is testing

Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaMicrowave AblationLiver Cancer+2 more
Sun Yat-sen University 274
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Testing effectiveness (Phase 2)UnknownNCT05578430
What this trial is testing

AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)

Who this might be right for
Resectable Hepatocellular Carcinoma
Sun Yat-sen University 54
Not applicableActive Not RecruitingNCT05637788
What this trial is testing

Artificial Intelligence and Hepatocellular Carcinoma

Who this might be right for
HCC
Humanitas Clinical and Research Center 535
Not applicableLooking for participantsNCT05596630
What this trial is testing

Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC

Who this might be right for
Carcinoma; Hepatocellular
Second Affiliated Hospital, School of Medicine, Zhejiang University 40
Large-scale testing (Phase 3)Study completedNCT04103398
What this trial is testing

TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaSorafenibTransarterial Chemoembolization
Sun Yat-sen University 162
Testing effectiveness (Phase 2)Study completedNCT00003557
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University of Chicago 16
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Early research (Phase 1)UnknownNCT03966209
What this trial is testing

Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Not applicableUnknownNCT06247293
What this trial is testing

Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy

Who this might be right for
Hyperthermic Intraperitoneal ChemotherapyHepatocellular CarcinomaRuptured Liver
Zhujiang Hospital 100
Not applicableStudy completedNCT04177316
What this trial is testing

Hypermethylation of VTRNA2-1 Promoter in HCC Outcome

Who this might be right for
Hepatocellular Carcinoma Resectable
Chang Gung Memorial Hospital 92
Post-approval studies (Phase 4)UnknownNCT02631499
What this trial is testing

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Who this might be right for
Carcinoma, HepatocellularNeoplastic Cells, Circulating
Fudan University 256
Not applicableUnknownNCT02830737
What this trial is testing

No-touch RFA Versus Traditional RFA for Small Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Southwest Hospital, China 178
Testing effectiveness (Phase 2)WithdrawnNCT03563170
What this trial is testing

QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma Recurrent
ImmunityBio, Inc.
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Early research (Phase 1)Study completedNCT01075113
What this trial is testing

Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
Virginia Commonwealth University 16
Testing effectiveness (Phase 2)WithdrawnNCT03634683
What this trial is testing

LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation

Who this might be right for
Recurrent Hepatocellular Carcinoma
Lion TCR Pte. Ltd.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243951
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaLiver Neoplasms
Shanghai Zhongshan Hospital 75
Load More Results